Using an app to combat skin conditions: Nia Health receives millions in funding

The Berlin-based health tech start-up Nia Health receives 3.5 million euros in a seed financing round.
The company originates from the Charité Universitätsmedizin Berlin and operates leading dermatology apps, including “Nia,” the most widely downloaded app for people with atopic dermatitis.
The company has a network of renowned cooperation partners consisting of pharmaceutical companies, health insurance companies and clinics.
The great potential lies above all in Nia Health’s expertise in the area of real-world evidence. This is completely anonymized medical information from the everyday care of patients. With its help, healthcare can be significantly improved.

 

Berlin, 15.5.2023 – Nia Health, a spin-off of Charité Universitätsmedizin Berlin, offers digital solutions for the treatment and support of sufferers of chronic skin conditions. Its products include digital therapeutics, such as the leading atopic dermatitis app Nia, and technologies for monitoring patients and conducting clinical trials. The start-up has now received €3.5 million in a seed funding round. The lead investor is High-Tech Gründerfonds. The other investors were adesso ventures, Ventura BioMed Investors, the fund of pharmaceutical industry expert Dr. Kurt Schwarz, and other investors.

The fresh capital will be used for expansion: It is planned to expand the market share in German-speaking countries, launch in other EU countries in the next 24 months and prepare for the US market entry. Furthermore, the funding will be used to further develop the innovative, AI-based technology that integrates machine vision, natural language processing and teledermatology.

The company’s technology is currently being used in a total of five clinical studies, including one at the Charité Universitätsmedizin Berlin to investigate the therapy-accompanying effectiveness of the Nia App – with success.

Read the full article here.

 

Back